Belite Bio (BLTE) said Sunday it struck a deal for the immediate exercise of outstanding warrants to purchase up to 651,380 shares at an exercise price of $44.14 per share for expected gross proceeds of around $28.8 million.
The company said it intends to use the net proceeds for general corporate purposes.
The company also said it will issue new warrants to purchase up to 651,380 ordinary shares with an exercise price of $70 per share for potential gross proceeds of about $45.6 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments